The potential of molybdenum substances to cause genotoxic effects has been studied previously. However, a review of existing in vitro data, including an assessment of relevance and reliability, has shown that inconsistent results have been observed in the past. To resolve the inconsistencies, new studies were performed with the highly soluble sodium molybdate dihydrate according to OECD test guidelines. In a bacterial reverse mutation assay sodium molybdate dihydrate did not induce reverse mutations in five strains of Salmonella typhimurium. No mutagenic or clastogenic effect was observed at the tk locus of L5178Y mouse lymphoma cells. In a micronucleus test in cultured human peripheral blood lymphocytes no clastogenic or aneugenic effects were seen. These results can be read across to other inorganic molybdenum substances, that all release the molybdate ion [MoO 4 ] 2À under physiological conditions as the only toxicologically relevant species. In summary, a weight of evidence assessment of all available in vitro data shows no evidence of genotoxicity of molybdenum substances.
Introduction
This paper presents new OECD Test Guideline (TG) 471, 476/490 and 487 compliant studies on genotoxicity testing of sodium molybdate dihydrate. These studies were conducted for hazard identification and risk assessment purposes in the context of compliance with the EU REACH Regulation, 1 after a review of the existing literature on genotoxicity of inorganic molybdenum substances identified a lack of reliable in vitro data. An approach for read-across/grouping among inorganic molybdenum substances is also presented, from which we conclude with a weight-of-evidence assessment of the in vitro genotoxic potential of inorganic molybdenum substances. Molybdenum is a naturally occurring element found at background levels in water, sediment and soil and plants. It is contained in various minerals, but only naturally-occurring molybdenite (MoS 2 ) is suitable for the industrial production of marketable molybdenum products. After mining and purification, molybdenite can be used as a lubricant, but the major production volume is roasted to technical grade molybdenum oxide. Further processing produces ferromolybdenum (primarily for inclusion of molybdenum in steel), as well as pure molybdenum trioxide, molybdenum salts and pure molybdenum metal. The main use for molybdenum is as an alloying element in steels and other alloys where it enhances corrosion resistance and specific properties such as hardenability and weldability. Main uses for molybdenum chemicals range from corrosion inhibition, to flame retardant/ smoke suppressant, to refinery catalysts, to micronutrient input into mineral supplements and fertilizers. Global use of molybdenum amounts to approx. 230,000 metric tonnes per year (IMOA, 2015) . Molybdenum is a bio-essential element for humans, animals and plants. It is well established that molybdenum is a component (co-factor) of enzymes which are essential for life. Without molybdenum, organisms cannot function and will show signs of deficiency (see for example Mendel and Bittner, 2006 and references therein) . Trace levels of molybdenum are found in a wide variety of foods and human exposure to molybdenum may occur via the diet and drinking water. Occupational exposure occurs during mining operations and industrial processing and use.
As is usual for many essential nutrients, recommendations are issued by different organisations in various countries on adequate intake levels, and minimum dietary requirements of molybdenum. For example, the USA National Academy of Sciences Food and Nutrition Board has established the estimated average requirement (EAR) of molybdenum for adults at 34 mg/day, corresponding to ca. 0.5 mg/kg bodyweight/day for a 70-kg adult (FNB, 2001 ). The National Societies for Nutrition of Germany, Austria and Switzerland (DACH, 2001 ) have derived an "estimate for adequate intake" for molybdenum of 50 e 100 mg/day (ca. 0.7 À 1.4 mg/kg bw/ day), whereas the British Expert Group on Vitamins and Minerals (BGVM, 2003) has estimated a molybdenum requirement in the range 100 e 300 mg/day (1.4 e 4.3 mg/kg bw/day).
The substance molybdenum trioxide, MoO 3 , based on animal inhalation toxicity and carcinogenicity studies by NTP (1997) , is currently classified in the EU, according to the Globally Harmonized System of Classification and Labelling of Chemicals, as a Category 2 carcinogen (EU CLP, 2008) . Similarly, the German Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area ("MAK Kommision") has assigned carcinogenicity category 3B to molybdenum trioxide (MAK, 2000) . Since genotoxic effects can be involved in carcinogenesis, the work presented in this paper can contribute to mechanistic toxicological investigations on molybdenum substances.
Read-across/grouping concept based on chemical speciation of dissolved inorganic molybdenum substances
Read-across is used to predict the toxicological properties of a target substance, by using data from the same endpoint from an analogous substance. Substances, whose toxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group (or category) of substances (ECHA, 2015) . For inorganic molybdenum substances, it is hypothesised that read-across is possible for systemic toxicity, including genotoxicity, based on the molybdate ion [MoO 4 ] 2-. The molybdate anion, containing hexavalent molybdenum(VI), is the only toxicologically relevant species released upon dissolution in aqueous media at physiologically relevant concentrations and pH conditions. The read-across hypothesis was verified based on scientific publications and in a set of experimental studies on UV spectra as described below.
The distribution of molybdenum species in aquatic media as a function of pH has been reviewed by Zeng and Cheng (2009) , based on computer simulations reported by Olazabal et al. (1992) . Based on these simulations the predominant molybdenum species at physiologically relevant concentrations (i.e. below ca. 10 mg/L) and pH is the molybdate anion. When the pH decreases, the [MoO 4 ] 2À ion becomes increasingly protonated. Only at very high concentrations are polymolybdate anionic species also observed (see also Ozeki and Kihara, 1988; Cruywagen et al., 2002) . The hexavalent molybdate is readily available for uptake by living organisms and is the form in which molybdenum is present in blood (Wood et al., 2012; Scaife, 1956) .
Based on experimentally recorded UV (ultraviolet) spectra, Mitchell (2009) has described the speciation of molybdenum released in water, for several commercially relevant inorganic molybdenum substances.
2 The substances were subject to standard OECD TG 105 compliant water solubility studies, followed by generation of UV spectra of the solutions or supernatants at the end of each test. The only molybdenum species produced from the molybdenum substances studied at physiologically relevant concentrations and pH was the molybdate ion, thus confirming theoretical predictions.
In consequence, with respect to systemic toxicity, read-across between inorganic molybdenum substances is justified. Toxicological test results obtained with a soluble molybdenum substance can therefore be read-across to other molybdenum substances e all inorganic molybdenum substances can also be designated as a category. Read-across to less soluble or even basically inert molybdenum substances is considered as conservative. The category concept is also acknowledged under the OECD Cooperative Chemicals Assessment Program (CoCAM). A SIDS Initial Assessment Profile (SIAP) on the category "highly soluble molybdenum salts" is available (OECD, 2013) . The most frequently used test substance in toxicological tests is sodium molybdate, often in the commercially most relevant dihydrate form. Adverse effects from the counter-ion sodium are not expected, and the substance is highly soluble.
3 To a lesser extent various ammonium molybdates and molybdenum trioxide have been used in toxicological tests, including genotoxicity testing. For molybdenum trioxide, depending on the test system, care needs to be taken when interpreting study results.
Readeacross potential from this substance may be limited for certain test systems/endpoints, because in addition to yielding the molybdate ion in solution it also releases protons that cause acidity
. The possible influence of this acidity on genotoxicity tests is addressed in this review when relevant.
Review of published in vitro genotoxicity data

Literature search
Prompted by data needs for compliance with EU Regulation No. 1907 , comprehensive literature searches for existing published data on toxicological effects of molybdenum substances were conducted by the authors and/or their co-workers in 2007. Following a review, including a reliability assessment of relevant publications, the three new studies presented in this paper were conducted to address identified data-gaps on in vitro genotoxicity. A literature search was also conducted again in July 2016, to identify any further published data for consideration in this paper (see Table 1 ).
A number of older studies related to the induction of genetic toxicity of molybdenum substances have been published that did not follow harmonised test guidelines and/or exhibit various shortcomings, rendering those studies of limited reliability. These studies are summarised in tabular format in Appendix A.
Bacterial test systems
The mutagenic activity of molybdenum substances has been investigated in a large number of bacterial reverse mutation assays.
An initial screening test, using the rec assay in recombinantdeficient strains of Bacillus subtilis was conducted by Nishioka (1975) for three molybdenum substances: in this assay, molybdenum pentachloride (MoCl 5 , purity not reported) was reported to be non-genotoxic, whereas potassium molybdate (K 2 MoO 4 , purity not reported) was weakly genotoxic, and ammonium heptamolybdate ((NH 4 ) 6 Mo 7 O 24 , purity not reported) was reported as genotoxic. It is questionable whether MoCl 5 represents a suitable test substance for this assay. MoCl 5 is described as "decomposes in water with violent reaction", as well as strongly irritating to corrosive (GESTIS, 2016) .
Since the rec assay only measures growth inhibition and not direct mutagenicity, further reverse mutation testing was conducted with the two above positive molybdenum substances. The induction of mutations in tryptophan requiring auxotroph E. coli strains WP2, WP2 uvrA and CM571 showed increased revertant numbers in two strains for ammonium heptamolybdate compared to the concurrent controls. No increase in revertants was found for potassium molybdate. Due to the lack of test substance characterisation, it remains unclear whether these findings can in fact be attributed to ammonium heptamolybdate.
The finding by Nishioka (1975) with ammonium heptamolybdate is in contrast to the results of the reverse bacterial mutation assay in S. typhimurium TA 98, 100, 1535 and 1537 reported by Arlauskas et al. (1985) , which showed no mutagenic effects in any of the tester strains. However, as with the study of Nishioka (1975) , a lack of test item characterisation limits the reliability of this study.
The absence of mutagenic effects reported by Nishioka (1975) for potassium molybdate is supported by the study of Kubo et al. (2002) using sodium molybdate, showing no increase in revertants of S. typhimurium strains TA98 and TA100 with and without metabolic activation (S9-mix). However, since only a brief summary is available, the validity of the study cannot be evaluated.
Similarly, ammonium octamolybdate (purity >99.9%), was reported as being non-mutagenic in the reverse mutation assay in S. typhimurium TA 98, 100, 1535 and 1537 either in the presence or absence of metabolic activation (Armitage, 1997) . The study is considered as reliable, as the design was in accordance with OECD TG 471 and the reporting was under GLP.
Molybdenum trioxide (MoO 3 , purity >98%) was comprehensively evaluated within the US National Toxicology Program in a series of in vitro genetic toxicity studies (NTP, 1997; Zeiger et al., 1992) . The bacterial reverse mutation test was conducted in S. typhimurium TA 97, 98, 100, 1535, 1537 using the pre-incubation method, and in the presence and absence of metabolic activation using a 10% and 30% rat and hamster S9-mix. The study design was similar to the OECD TG 471 test protocol. The maximum test concentration was 10 mg/plate, limited by experimental design. For the tests without S9-mix, a confirmatory experiment ("Trial 2") was not performed when cytotoxicity was observed in Trial 1. Molybdenum trioxide, tested at 0.01e10 mg/plate, did not induce mutations in any of the S. typhimurium strains tested.
These findings are consistent with the results reported by Jones (2004) . No mutagenic effects were observed for molybdenum trioxide (produced by sublimation, purity 100%) in the reverse bacterial mutation assay in S. typhimurium TA 97, 98, 100, 1535, 1537 and E. coli WP2P uvrA in the presence and absence of metabolic activation in two independent experiments. The study was conducted in accordance with OECD TG 471 and under GLP. Hasegawa et al. (2012) analysed the influence of particle size on the mutagenicity of elemental molybdenum particles (4.51 mm and <100 nm, as per the manufacturers specifications, purity >99.8%) in S. typhimurium TA 98, 100, 1535, 1537 and E. coli WP2-uvrA. Molybdenum metal powder of both sizes did not show any mutagenic effects in bacteria in the presence or absence of metabolic activation.
Studies in mammalian cells in vitro
Only a small number of published studies are available on the genetic toxicity of molybdenum substances in mammalian cells. One comprehensive study was conducted within the National Toxicology Program (1997) , investigating the induction of chromosomal aberrations and sister chromatid exchanges in CHO cells. Those studies were conducted with molybdenum trioxide either in the presence or absence of metabolic activation (S9-mix). There was neither any evidence for an induction of chromosomal aberrations, nor for sister chromatid exchanges. Gibson et al. (1997) evaluated the concordance of the in vitro micronucleus assay in Syrian Hamster Embryonic (SHE) cells and the SHE transformation assay by using chemicals previously tested in the NTP programme. Although the bacterial reverse mutation test, in vitro chromosome aberration and sister chromatid exchange by NTP were negative with and without metabolic activation, both the SHE transformation and micronucleus assay were positive for molybdenum trioxide. Molybdenum trioxide was supplied by the NTP and tested at doses of 250, 500 and 750 mg/mL.
The MN assay displayed a dose-dependent increase of micronucleated binucleated cells. However, a pH control was not reported, despite the known acidic reaction of MoO 3 upon dissolution which may have contributed to pronounced cytotoxicity/clastogenicity. A low pH might account for the reduced number of binucleate cells analysed (250 instead of 1000) above the lowest of the three concentrations.
Molybdenum trioxide is known to lower the pH upon dissolution in water. Fox (2005) conducted an in vitro micronucleus assay in human lymphocytes with pH adjustment. Human peripheral blood lymphocytes were incubated in the presence and absence of metabolic activation (S9-mix) for 3 h and without metabolic activation for 20 h. For all experiments with pH adjusted to 7.3, no increase of the micronucleus frequency was observed when tested up to concentrations limited either by cytotoxicity (at 1439 mg/mL in experiment 2 after 3 h and in experiment 3 after 20 h exposure in the absence of S9 and in experiment 2 after 3 h exposure in the presence of S9) or precipitation (at 1000 mg/mL and higher). Titenko-Holland et al. (1998) describe an in vitro micronucleus assay in human lymphocytes from two donors. The test substances were hexaammonium heptamolybdate tetrahydrate, tested at four concentrations up to 2471 mg/mL (2 mmol/L), and sodium separately. Yet the authors performed a marked statistical overanalysis of the results: "Effects of potential confounding factors on the dose-response were also assessed by fitting more complex logistic regression models which considered donor and experiment in addition to dose. However, there was negligible experiment variability, while donors differed significantly (P < 0.001). Thus, the P-values reported … were calculated after adjustment for effects of experiment and donor variability.". The high variability between the two donors could have been assessed better by using lymphocytes from further donors. Based on these weaknesses in the study by Titenko-Holland et al. (1998) it does not appear justified to consider this study as a valid "positive" micronucleus study. The publication by Titenko-Holland et al. (1998) has also been discussed, criticised and subsequently disregarded by the Technical Committee for Classification and Labelling of the European Chemicals Bureau, during discussions on a proposed hazard classification of molybdenum trioxide for mutagenicity (ECB, 2005) .
Recently, molybdenum trioxide was tested in a set of ToxTracker ® indicator tests . This set of tests has recently been proposed as an additional assay in an integrative test strategy for cancer hazard identification (Luijten et al., 2016) . ToxTracker ® employs of a panel of six different mouse embryonic stem (mES) cell line with green fluorescent protein (GFP) reporters, that are activated by four distinct biological responses: general cellular stress, DNA damage, oxidative stress and the unfolded protein response. Furthermore, cytotoxicity is assessed based on cell survival, measured by flow cytometry. Experiments were conducted in the absence and presence of an S9 rat liver extract-based metabolising system. For details on the methodology and validation please refer to and references therein. Molybdenum trioxide was tested at 0, 62.5, 125, 250, 500 and 1000 mg/ mL, with the highest concentration reaching the limit of solubility.
Low levels of cytotoxicity (20%) were observed at 1000 mg/mL.
Molybdenum trioxide did not induce the Bscl2-GFP genotoxicity reporter that is associated with generation of promutagenic DNA lesions, nor the Rtkn-GFP genotoxicity reporter for DNA strand breaks. Molybdenum trioxide did not cause a significant increase of the oxidative stress or protein damage reporters. There was no indication for metabolic activation of molybdenum trioxide. As noted above, the genotoxicity studies of molybdenum and molybdenum substances published in the past manifest some considerable inconsistencies: both positive and negative findings have been reported for mutations in bacterial and mammalian cells although many are in studies with significant limitations. In order to resolve these discrepancies, new studies for these endpoints were performed using well-characterised samples of sodium molybdate dihydrate, and carried out according to current (OECDrecommended) protocols. This readily soluble test substance was selected as a source of the molybdate ion [MoO 4 ] 2-as it is representative of soluble molybdenum compounds that give rise to molybdate ions under physiological conditions. The results are presented here and discussed in the light of the published findings.
Materials and methods
Test chemicals
Sodium molybdate dihydrate 4 was supplied by Climax Molybdenum, USA. Stock solutions were prepared by dissolution in purified water (with the application of a conversion factor of 1.175 for water content), membrane filter-sterilised (0.2 mm pore size) and subsequently diluted as required using purified water. All test concentrations are expressed in terms of mg/mL or mg/plate of (anhydrous) sodium molybdate. The positive control substances sodium azide (NaN 3 ), mitomycin C (MMC), vinblastine (VIN), and methyl methanesulfonate (MMS) were formulated in water; 2-nitrofluorene (2NF), 9-aminoacridine (AAC), benzo[a]pyrene (B[a]P), 2-aminoanthracene (AAN), and cyclophosphamide (CPA) were formulated in DMSO. All chemicals and reagents were obtained from Sigma-Aldrich Chemical Co. (Poole, UK) or equivalent suppliers.
Rat liver S9
Liver post-mitochondrial fraction (S9), prepared from male Sprague Dawley rats induced with Aroclor 1254, was obtained from Molecular Toxicology Inc., Boone, North Carolina, USA.
In the bacterial reverse mutation test, metabolic activation was provided by a S9-mix composed of 10% S9, 8 mM MgCl 2 , 33 mM KCl, 1.5 mg/mL glucose-6-phosphate, 3.2 mg/mL b-nicotinamide adenine dinucleotide phosphate (NADP), 0.1 M phosphate buffer, 40 mg/mL L-histidine HCl (in 250 mM MgCl 2 ), and 49 mg/mL dbiotin. An equivalent volume of buffer (1.5 mg/mL glucose-6-phosphate, 40 mg/mL L-histidine HCl (in 250 mM MgCl 2 ) and 49 mg/mL d-biotin) was used for treatments in the absence of S9.
For the in vitro micronucleus and mouse lymphoma assays the S9-mix used for metabolic activation was prepared by mixing glucose-6-phosphate (180 mg/mL), NADP (25 mg/mL), KCl (150 mM) and rat liver S9 in the ratio 1:1:1:2. The final concentration of the liver homogenate in the test system was 2%; an equivalent volume of 150 mM KCl was added to cultures treated in the absence of S9.
Ames test
Five strains of Salmonella typhimurium bacteria (TA98, TA100, TA1535, TA1537 and TA102) were used in this study and were originally obtained from the UK NCTC or Glaxo Group Research Limited (strain TA102).
Bacteria were cultured at 37 C for 10 h, with shaking, in nutrient broth containing ampicillin (TA98, TA100) or ampicillin and tetracycline (TA102) as appropriate. For all experiments, the highest concentration tested was 5000 mg/plate, the maximum concentration recommended by OECD TG 471 (OECD, 1997a). For plate incorporation assays (Maron and Ames, 1983) , bacteria, control or sodium molybdate dihydrate formulation, and 10% S9-mix or buffer were added to molten agar at 46 ± 1 C, mixed rapidly, and poured onto Vogel-Bonner E plates. For the pre-incubation assay (Yahagi et al., 1975) sodium molybdate dihydrate or control formulation, bacteria, and 10% S9-mix were mixed and incubated at 37 ± 1 C for 1 h prior to the addition of molten agar and plating. The pH value of the stock solution and of the treatment mixture using the highest concentration of sodium molybdate dihydrate was measured, in order to exclude any artefacts that may be exerted by pH shifts originating from the dissolved sodium molybdate dihydrate. Once the agar had set, triplicate plates per concentration (five plates for vehicle control) were incubated at 37 C in the dark for 3 days. Colonies were counted using the Sorcerer Colony Counter (Perceptive Instruments, Ltd., Suffolk, UK) or manually when confounding factors such as precipitation affected the accuracy of the automated counter. The background lawn was inspected for signs of toxicity. Data were confirmed to meet the following acceptability criteria: 1) the mean vehicle control counts fell within the laboratory's historical 99% confidence intervals for group means and/or 2) each vehicle control plate count fell within the historical 99% reference ranges, and 3) the positive control plate counts were comparable with the historical 99% reference ranges. Results were considered to be positive for mutation if a Dunnett's test (Venitt et al., 1983; Mahon et al., 1989 ) gave a significant response (p 0.01) that was concentration related and the positive response was reproducible.
Mammalian cell gene mutation tests
The methodology and fluctuation (microwell) protocol used in this study was conducted in compliance with OECD TG 476 (OECD, 1997b) , which was the current guideline at the time of the assay. In general, the methodology used was consistent with the current requirements of OECD TG 490 (OECD, 2016) . The stock of L5178Y tkþ/-(3.7.2C) mouse lymphoma cells was originally provided by Dr. Donald Clive (Burroughs Wellcome Co.).
Cells were cultured in RPMI (Roswell Park Memorial Institute) medium containing 100 units/mL penicillin, 100 mg/mL streptomycin, 2.5 mg/mL amphotericin B, 0.5 mg/mL Pluronic, and 5 or 10%
heat inactivated horse serum. For 3 h exposures, at least 10 7 cells in a volume of 18.8 mL of RPMI medium (5% serum) were seeded in sterile 50 mL centrifuge tubes. For 24 h exposures, at least 4 Â 10 6 cells in a volume of 19.8 mL RPMI medium (10% serum)
were seeded in 75 cm 2 tissue culture flasks. For all exposure conditions, 0.2 mL of vehicle, test article, or positive control solutions was added to the culture. In Experiments 1 and 2, the maximum concentration tested was 2060 mg/mL (equivalent to 10 mM), in the absence and presence of S9. No marked cytotoxicity or post-treatment precipitate was observed. Duplicate (single for positive controls) exposures were performed. After incubation for either 3 h or 24 h at 37 C, cultures were centrifuged at 200 g for 5 min, washed, and resuspended in 20 mL RPMI medium (10% serum; cell densities were adjusted to 2 Â 10 5 cells/mL). Sub-culturing was performed as necessary to avoid overgrowth of cultures and at the end of the expression period, the cells were counted and seeded. For viability plating, cells were diluted to 8 cells/mL in RPMI medium (20% serum) and the plates were incubated at 37 ± 1 C in a humidified incubator gassed with 5% v/v CO 2 in air for 7 days. Wells containing clones were identified and counted. Cytotoxicity was measured by relative total growth (RTG), compared to the control, that takes into account all cell growth and cell loss during the treatment period and the 2 day expression period (relative suspension growth, RSG), and the cells' ability to clone 2 days after treatment (viability). For the quantification of induced mutations cells were diluted to 10 5 cells/mL in RPMI medium (20% serum) containing 3 mg/mL TFT and incubated at 37 ± 1 C in a humidified incubator gassed with 5% v/v CO 2 in air for 12 days. Wells containing clones were identified and counted. In addition, wells containing large and small colonies were scored. Molecular analysis has indicated that the large colonies tend to represent events within the gene (base-pair substitutions and deletions) whereas small colony mutants often involve large genetic changes frequently visible as chromosome aberrations (Moore et al., 1985; Applegate et al., 1990) . The significance of increases in mutant frequencies (total wells with clones), by comparison with concurrent controls and the global evaluation factor (GEF), was assessed according to the recommendations of the Mouse Lymphoma Workgroup (Moore et al., , 2006 (Moore et al., , 2007 . The data were checked for a linear trend in mutant frequency with treatment concentration using weighted regression.
The test item was considered to be mutagenic in this assay if the mutation frequency (MF) of any test concentration exceeded the sum of the mean control mutant frequency plus GEF of 126 mutants per 10 6 viable cells and the linear trend test was positive.
In vitro micronucleus test
This study was conducted in accordance with OECD TG 487 (OECD, 2007) . Whole blood cultures were established by placing heparinized blood into HEPES (2-(4-(2-hydroxyethyl)-1-piperazinyl)-ethanesulfonic acid) buffered RPMI medium containing 20% (v/v) heat inactivated foetal calf serum and 50 mg/mL gentamycin. Phytohaemagglutinin (PHA, reagent grade, Gibco) was included in the culture medium at a final concentration of approximately 2% to stimulate the lymphocytes to divide.
Replicate cultures (four for vehicle controls, two for positive controls and each test article concentration) were established for each test condition. Cultures were incubated at 37 C for 48 h and rocked continuously.
S9 or KCl was added and the cultures were treated with the test article or controls. The highest concentration tested under all treatment regimes was 2060 mg/mL (equivalent to 10 mM). Cytochalasin B in DMSO was added to the 24 h continuous cultures at the time of treatment. Cultures were incubated at 37 C for 3 h (±S9) or 24 h (-S9). Following exposure, the 3 h (±S9) cultures were centrifuged (300 g for 10 min) and resuspended in fresh medium containing foetal calf serum, gentamycin and Cytochalasin B at 6 mg/mL. These cultures were allowed to recover at 37 C for 21 h. At the defined sampling time, cultures were centrifuged at 300 g for 10 min. Pelleted cells were resuspended in 0.075 M KCl at 37 C to allow cell swelling to occur. Cells were then fixed by dropping the KCl suspension into fresh, cold methanol/glacial acetic acid (3:1, v/ v). The fixative was changed by centrifugation (300 g, 10 min).
Several drops of cell suspension were gently spread onto multiple clean microscope slides and allowed to dry. The slides were stained for 5 min in filtered 4% (v/v) Giemsa in Gurr's phosphate buffer, pH 6.8, rinsed, dried, and mounted with coverslips. Cytotoxicity was measured using the relative Replication Index (RI) compared to the vehicle control as follows: slides were examined for proportions of mono-, bi-, and multinucleate cells (200 cells/ culture). Slides from the concentration at which approximately 50% (typically 45%e55%) reduction in replication index (RI; [number binucleate cells þ 2(number multinucleate cells)]/total number of cells in treated cultures) had occurred and two lower concentrations were selected for microscopic analysis, such that a range of cytotoxicity from maximum (not excessive) to little was covered. In the absence of toxicity, the highest concentration was to be analysed. Coded slides were analysed by scoring 1000 binucleate cells (where possible) from each culture (2000 per concentration) for micronuclei.
The proportions of binucleate cells with micronuclei in the replicate samples were used to establish acceptable heterogeneity between replicates by means of a binomial dispersion test. The proportion of binucleate cells with micronuclei for each treatment condition was compared with the proportion in negative controls by using Fisher's exact test. Probability values of p 0.05 were considered significant. The criteria for a positive response in the assay were a statistically significant increase in the frequency of binucleate cells with micronuclei at one or more concentrations that exceeded the normal range in both replicates, and observation of a concentration-related increase in the proportion of binucleate cells with micronuclei.
Results
Ames test
The results of the bacterial reverse mutation experiments with sodium molybdate dihydrate are summarised in Table 2 and  Table 3 .
A first mutagenicity experiment ( In a second mutagenicity test (Table 3) in all bacterial strains, seven narrowed concentration intervals were employed covering the range 156.25e5000 mg/plate to better examine concentrations of sodium molybdate dihydrate approaching the maximum test concentration. In this experiment, all treatments in the presence of S9 included a pre-incubation step to increase the sensitivity for detection of mutagenic chemicals in this assay system. In addition, plate incorporation treatments of strain TA102 in the absence and presence of S9 were included at the same concentrations as the first experiment (1.6e5000 mg/plate) in order to determine the reproducibility of increases in revertants observed in the first experiment. Following all of these treatments there was no evidence of toxicity or precipitation of the sodium molybdate. A statistically significant increase (1% level, Dunnett's test) in revertant numbers was observed in strain TA102 at an intermediate concentration of 200 mg/plate when treated in the presence of S9 using preincubation methodology, but a similar response was not observed when plate incorporation methodology was employed in the presence of S9. In addition, statistically significant increases (1% level, Dunnett's test) were observed following treatments of strain TA100 in the absence of S9 at 200 mg/plate and in strain TA1535 in the absence of S9 at 2500 mg/plate. No mutagenic effect of sodium molybdate dihydrate was detected in the other strains in the absence or presence of S9.
In all experiments the mean numbers of revertant colonies on negative control plates all fell within acceptable ranges, and were significantly elevated by the positive control treatments.
Although some statistically significant increases in revertant numbers were observed in strains TA100, TA1535 and TA102, the increases were all small and showed no evidence of a dose-related response. In addition, they were not reproduced under comparable treatment conditions in the respective other, independent experiment (compare Tables 2 and 3 ) and were therefore considered to be biologically irrelevant. Overall the results show that sodium molybdate dihydrate did not induce reverse mutations in strains of Salmonella typhimurium.
Mammalian cell gene mutation test
The results of the mouse lymphoma Tk mutation test with sodium molybdate dihydrate are summarised in Table 4 and Table 5 .
In Experiment 1 the highest concentration tested, 2060 mg/mL, gave 87% and 111% RTG in the absence and presence of S9, respectively.
In Experiment 2 the highest concentration tested, 2060 mg/mL, gave 62% and 91% RTG in the absence and presence of S9, respectively. This indicates that no marked toxicity was observed at 10 mM (the maximum concentration in accordance with OECD TG 476 (OECD, 1997b) in the absence and presence of S9 in Experiments 1 and 2.
For the plating of TFT resistance, in experiments 1 and 2, the mutant frequencies of the concentrations plated were all less than the sum of the mean control mutant frequency plus the GEF (126 mutants per 10 6 viable cells), confirming that sodium molybdate dihydrate did not induce mutation at the tk locus of L5178Y mouse lymphoma cells. Mutant frequencies in negative control cultures fell within acceptable ranges (50e170 mutants per 10 6 viable cells) and clear increases in mutation were induced by the positive control chemicals.
Overall the results show that sodium molybdate dihydrate did not induce mutation at the tk locus of L5178Y mouse lymphoma cells.
In vitro micronucleus test
The results of the micronucleus experiments with sodium molybdate dihydrate are summarised in Table 6 . A suitable range of concentrations of test article to be tested for micronucleus induction was selected on the basis of results of a preliminary range finder toxicity experiment. No evidence of marked toxicity was observed following 3 h treatments (in the presence or absence of S9), as would be manifest as an increase in the cytotoxicty (%) (see Table 6 ). Consequently, the highest concentration tested (2060 mg/ mL) was selected as the maximum concentration for micronucleus analysis. 1191 mg/mL, inducing 56% cytotoxicity, was selected as the maximum concentration for micronucleus analysis for the 24-h treatment in the absence of S9.
Appropriate negative (vehicle) control cultures were included in the test system under each treatment condition. The proportion of micronucleated binucleate cells (MNBN) in these cultures fell within current historical vehicle control ranges. Clastogenic and aneugenic positive control chemicals induced statistically significant increases in the proportion of cells with micronuclei.
3-hour treatment with sodium molybdate dihydrate in the absence of S9 resulted in frequencies of MNBN cells which were slightly elevated (p 0.05) when compared to those observed in concurrent vehicle controls at the lowest (1362 mg/mL, 0.7%) and the highest (2060 mg/mL, 0.95%) concentrations analysed. However, these frequencies were set against low vehicle control values (0.25%), with the MNBN cell frequency of all test article treated cultures falling within the current historical vehicle control range (0.1e1%), with no evidence of a concentration related response. The MNBN cell frequency of a single culture at the highest concentration analysed (2060 mg/mL) marginally exceeded the 95th percentile of the current historical vehicle control range (0.1e1%), but was within the observed range (0.1e1.10%). This isolated increase was not observed in the replicate culture and therefore did not meet the laboratory's criteria for follow-up experimentation; overall these observations were considered of no biological relevance. 3-hour treatment of cells with sodium molybdate dihydrate in the presence of S9 resulted in frequencies of MNBN cells which were similar to and not significantly (p 0.05) different from those observed in concurrent vehicle controls for all concentrations analysed. The MNBN cell frequency of all sodium molybdate dihydrate treated cultures fell within the current historical vehicle control range (0.1e1.2%).
Continuous 24-h treatment of cells with sodium molybdate dihydrate in the absence of S9 resulted in frequencies of MNBN cells that were generally similar to those observed in the concurrent vehicle controls. The exception to this was at the highest concentration analysed (1191 mg/mL), where a small but statistically significant (p 0.01) increase in MNBN cells was observed (1.15%). However, this increase was associated with an elevated number of MNBN cells in just one of the replicate cultures, with no other test article treated culture demonstrating elevated MNBN cell values. Furthermore, this concentration was associated with cytotoxicity which was at the upper end of the acceptable range (56%). As such, the data did not meet the laboratory's criteria for follow-up investigations and the isolated increase was considered of highly questionable biological importance.
It is concluded that sodium molybdate dihydrate did not induce micronuclei in cultured human peripheral blood lymphocytes.
Discussion
The genotoxicity of molybdenum substances has been investigated in a comprehensive range of different test systems, including in vitro bacterial and mammalian cells systems.
Unequivocally negative results were obtained in guidelineconform, bacterial reverse mutation assays with molybdenum trioxide (Zeiger et al., 1992; NTP, 1997; Jones, 2004 ). An equally negative outcome was observed with molybdenum metal particles with a particle size 4.5 mm and <100 nm (Hasegawa et al., 2012) . In the published literature, inconsistent results in the Ames test were observed for ammonium heptamolybdate: a positive response in the publication by Nishioka (1975) is contradicted by a clear negative outcome in the work by Arlauskas et al. (1985) . All other molybdates, sodium molybdate, potassium molybdate and ammonium octamolybdate did not show positive Ames results NS Not significant (The control mutant frequency was compared with each test article treatment and the data were checked for a linear trend in mutant frequency with treatment concentration using weighted regression. The test for linear trend is one-tailed, therefore negative trend was not considered significant.). a 5-TFT resistant mutants/10 6 viable cells 2 days after treatment. 
NS Not significant (The control mutant frequency was compared with each test article treatment and the data were checked for a linear trend in mutant frequency with treatment concentration using weighted regression. The test for linear trend is one-tailed, therefore negative trend was not considered significant.). a 5-TFT resistant mutants/10 6 viable cells 2 days after treatment. (Nishioka, 1975; Kubo et al., 2002; Armitage, 1997) . The positive finding with ammonium heptamolybdate (Nishioka, 1975) has also not been reproduced in the most recent robust guideline-conform Ames study with sodium molybdate dihydrate reported above (Beevers, 2009 ). All previously published investigations on the genetic toxicity in mammalian cells gave inconsistent results. The positive MN findings in SHE cells (Gibson et al., 1997) are surprising, since molybdenum trioxide returned a negative result in the CA assay in CHO cells (NTP, 1997) and it is noted that SHE cells are not used in routine regulatory MN assays. It appears likely that the positive findings in SHE cells were primarily caused under conditions of excessive toxicity, presumably caused by pH shift and precipitation, since the positive MN results were only seen at the highest concentration tested. At lower concentrations, there was no increase in MN frequency, and furthermore, a dose-response relationship was not observed. It is known that molybdenum trioxide causes a reduction in pH on dissolution in water and a repeat of the study design by Gibson et al. (1997) , but with a control for pH shifts and excessive toxicity, did not show an increase in MN frequencies (Fox, 2005) . Furthermore, in mouse embryonic stem cells, molybdenum trioxide did not activate any GFP reporter for general cellular stress, DNA damage, oxidative stress or unfolded protein response in a ToxTracker ® assay . The negative result in a recent guideline-conform micronucleus test with sodium molybdate dihydrate confirms the otherwise consistent lack of clastogenic and aneugenic effects of molybdenum substances tested (Taylor, 2009) . Further, no mutagenic or clastogenic effect of sodium molybdate dihydrate was observed at the tk locus of L5178Y mouse lymphoma cells (Lloyd, 2009) . In summary, the weight of evidence of all available in vitro genotoxicity data clearly indicates an absence of genotoxic effects in cytogenicity studies as well as in bacterial or mammalian gene mutation assays. On the basis of the read-across concept presented above, one may safely assume that the negative findings for sodium molybdate dihydrate can be read-across to all other inorganic molybdenum substances and molybdenum metal.
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Appendix A
The literature search for genetic toxicity references of molybdenum and molybdenum substances identified several studies which do not fulfil the relevance, reliability and adequacy criteria usually employed in chemicals hazard assessment. The studies are discussed below in brief for information purposes only.
Specifically, studies addressing DNA damage in bacteria (e.g. as assessed in the rec-assay), induction of SCE in mammalian cells, or tests in yeasts are no longer recommended as part of regulatory testing by many agencies worldwide and there are no up-to-date OECD guidelines for their conduct. The results obtained in these studies are difficult to interpret since, e.g. the historical database is outdated or not reported which renders the evaluation of sensitivity and specificity of the test system difficult.
Further, protocols employed for conduct of the in vitro comet assay do not meet minimal quality standards for conduct of the comet assay. Application of the comet assay to intact cells and tissues must carefully control for natural process that can produce DNA fragmentation and false positive assay outcomes. Cytotoxicity (Henderson et al., 1998; Fairbairn et al., 1996) , apoptosis (Choucroun et al., 2001; Fairbairn et al., 1996) , oxidative and temperature stress and terminal differentiation must all be carefully assessed for their impact upon assay outcomes. Information can also be obtained from detailed evaluation of the shape of Comet tails and the distribution of DNA within the tail (Lee et al., 2003) . Little meaningful information is provided on any of these accepted response parameters in the studies summarised below and they controlled for none of these sources of artificial false positives. Interpretation of the relevance of both positive and negative results from the tests systems mentioned above is therefore unclear and was not used for the current assessment of in vitro genotoxicity of molybdenum and molybdenum substances. Zelikoff et al. (1985) : A comparison of metal toxicity in a microtiter assay system using Escherichia-coli and V-79 cells. Environmental Mutagenesis (1985) Vol. 7, No. SUPPL. 3, pp. 7e8.
"NaMoO 4 ", no further details available Microtitre assay using Chinese hamster lung cells (V79) and E.coli. Test concentrations not reported: the only statement is that "2-fold serial dilutions" were used. The "minimum toxic dose" was determined in V79 cells, and the "toxic endpoint" in E.coli.
Results are reported as follows:
"Out of 20 compounds tested, NaHSO 4 , NaMoO 4 and NaNO 2 were equally toxic, on a molar basis, to both systems".
This reference is considered an unreliable source, because of several deficiencies. Only a brief conference abstracts is available, with incomplete information on test items, test system and results. The test substances is described as NaMoO 4 , which is an implausible chemical formula (Na 2 MoO 4 is a common molybdate salt).
